Ropustin
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Ropustin, covering 2024-07-24 to 2024-07-24. Get the full timeline:
Most recent: Clinical Trial Update: Ropustin for Refractory Aplastic Anaemia After Radiotherapy - a Single-centre, Prospective, Open-label, Single-arm Study [Phase 4]